F: LiptoCitro
Phytobiotics and Prebiotics
A new alternative for sustainable aquaculture by Santiago de la Cuesta, Ignacio López, Antonio Martínez and Laura Muñoz, Spain Email: liptosa@liptosa.com, Website: www.liptosa.com
E
nvironmentally friendly LiptoCitro is a prebiotic, immunoestimulant and growth promoter with a proved antibacterial activity. It can be used at any stage of the fish production cycle and no withdrawal period is needed because it does not contain any antibiotics. It is used at dosage rates of 2.5Kg/M/tonne and it can be incorporated in the feed mill during diet manufacture, or top-dressed on the feed using oil or molasses at the farm. It is made of a combination of prebiotics, plant extracts and plant essences and does not develop off-flavours in either fish or crustaceans. LiptoCitro is capable of improving nutrient digestibility, favouring beneficial intestinal flora, eliminating pathogenic bacteria, and promoting the immune system, resulting in higher resistance to stress and disease and improved growth, survival, FCR, production and cost-efficiency, even in the event of bacterial, viral and some parasitic disease outbreaks.
7,97%
LiptoCitro trial data
the lots of infected fish that were fed with LiptoCitro improved significantly, Trials have been conducted in laboratories, research centres and farms Table 1: Minimum Inhibitory Concentration (MIC) of with a range of fish and shrimp LiptoCitro against bacterial strains tested in VISAVET species and pathogens. laboratory, Spain Trials conducted in the Microorganism MIC Veterinary Sanitary Vigilance Centre (VISAVET) of the Complutense University of Madrid, Spain showed that LiptoCitro possessed strong in vitro antibacterial activity against a range of pathogenic bacterial species commonly encountered in aquaculture production systems (Table 1). Trials carried from May to November in a commercial farm in Spain showed the efficacy of Liptocitro to control Haemorrhagic Enteritis outbreaks in rainbow trout (Oncorhynchus mykiss). A total amount of 1,700 MT of commercial feed with LiptoCitro added at 2.5Kg/MT was used. All the fish had the same handling and usual European vaccine prophylaxis. In the control lots, which were not fed Liptocitro, several Enteritis outbreaks occurred over the six month trial period and the fish had to be treated with antibiotics. However,
Aeromonas hydrophila
3 mg/ml
Aeromonas salmonicida subsp. salmonicida
1 mg/ml
Listonella anguillarum
6 mg/ml
Listonella anguillarum CECT 522
3 mg/ml
Leucothrix mucor DSM 2157T
1 mg/ml
Vibrio penaeicida DSM 14398T
3 mg/ml
Vibrio harveyi CECT 525T
1 mg/ml
Vibrio parahaemolyticus
6 mg/ml
Vibrio ordali
6 mg/ml
Vibrio vulnificus
1 mg/ml
Vibrio vulnificus CECT 529 Vibrio alginolyticus
0.1 mg/ml 6 mg/ml
Flavobacterium psycrophilum DSMZ 3660T
3 mg/ml
Edwarsiella ictaluri CECT 885T
13 mg/ml
Brevundimonas diminuta CECT 317T
1 mg/ml
Pseudomonas anguilliseptica
0.1 mg/ml
Pseudomonas fluorescens
3 mg/ml
Yersinia ruckeri
3 mg/ml
Photobacterium damselae subsp. piscicida
3 mg/ml
Photobacterium damselae subsp. damselae
6 mg/ml
Lactococcus garvieae
6 mg/ml
Streptococcus iniae CCUG 27303T
13 mg/ml
Streptococcus difficilis DSZM 16828
13 mg/ml
Streptococcus parauberis
6 mg/ml
Mycobacterium chelonae CCUG 47445T
13 mg/ml
24 | International AquaFeed | May-June 2010
Mycobacterium marinum
0.1 mg/ml